Alcon Inc. (ALC)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:667
% of all portfolios:0.102%
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
AKO Capital Reduce 3.35% 213,488 0.28
Q2  2024
AKO Capital Reduce 1.92% 124,854 0.15
Q1  2024
AKO Capital Reduce 1.53% 100,907 0.12
Q2  2023
AKO Capital Reduce 1.29% 85,028 0.11
Q4  2022
AKO Capital Reduce 2.07% 119,022 0.13
Q3  2022
Kahn Brothers Group Sell 100.00% 3,415 0.03
Q2  2022
AKO Capital Reduce 12.30% 657,631 0.64
Q4  2021
AKO Capital Reduce 4.05% 224,341 0.19
Q3  2021
AKO Capital Reduce 7.29% 436,165 0.37
David Rolfe - Wedgewood Partners Sell 100.00% 54,875 0.56
Q2  2021
AKO Capital Reduce 4.53% 283,586 0.22
David Rolfe - Wedgewood Partners Reduce 79.84% 217,262 2.22
Q1  2021
David Rolfe - Wedgewood Partners Reduce 6.00% 17,361 0.19
Lee Ainslie - Maverick Capital Sell 100.00% 4,327 0.00
Q4  2020
David Rolfe - Wedgewood Partners Reduce 5.29% 16,162 0.16
Q3  2020
David Rolfe - Wedgewood Partners Reduce 4.58% 14,682 0.13
Q2  2020
David Rolfe - Wedgewood Partners Reduce 6.67% 22,900 0.22
Tweedy Browne Co. - Tweedy Browne Value Fund Sell 100.00% 28,731 0.47
Kahn Brothers Group Sell 100.00% 3,956 0.04
Q1  2020
Kahn Brothers Group Reduce 16.82% 800 0.01
David Rolfe - Wedgewood Partners Reduce 26.30% 122,493 1.18
Q4  2019
Kahn Brothers Group Reduce 2.46% 120 0.00
David Rolfe - Wedgewood Partners Reduce 28.61% 186,632 1.07
Q3  2019
Kahn Brothers Group Reduce 5.34% 275 0.00
AKO Capital Reduce 13.28% 323,227 0.46

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.